AMERIPRISE FINANCIAL INC - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 133 filers reported holding INSMED INC in Q2 2018. The put-call ratio across all filers is 4.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$47,387,004
+20.8%
1,876,713
+0.9%
0.02%
+33.3%
Q2 2023$39,229,205
+14.8%
1,859,204
-7.3%
0.01%
+9.1%
Q1 2023$34,183,836
-43.0%
2,004,917
-33.2%
0.01%
-47.6%
Q4 2022$59,948,000
-4.2%
3,000,301
+3.2%
0.02%
-8.7%
Q3 2022$62,600,000
+17.2%
2,906,206
+7.3%
0.02%
+21.1%
Q2 2022$53,426,000
-34.8%
2,709,180
-22.2%
0.02%
-20.8%
Q1 2022$81,880,000
-27.7%
3,484,229
-16.2%
0.02%
-22.6%
Q4 2021$113,276,000
-1.4%
4,158,422
-0.3%
0.03%
-16.2%
Q3 2021$114,832,000
-0.7%
4,169,652
+2.6%
0.04%
+2.8%
Q2 2021$115,688,000
+0.4%
4,064,771
+20.2%
0.04%
-5.3%
Q1 2021$115,185,000
+17.6%
3,381,817
+15.0%
0.04%
+8.6%
Q4 2020$97,927,000
+29.2%
2,941,597
+24.8%
0.04%
+12.9%
Q3 2020$75,773,000
+8.7%
2,357,602
-6.8%
0.03%
+3.3%
Q2 2020$69,688,000
+113.0%
2,530,610
+24.0%
0.03%
+76.5%
Q1 2020$32,716,000
-40.1%
2,040,997
-10.7%
0.02%
-26.1%
Q4 2019$54,601,000
+64.2%
2,286,384
+21.3%
0.02%
+53.3%
Q3 2019$33,246,000
+353.1%
1,884,688
+557.7%
0.02%
+400.0%
Q2 2019$7,337,000
+0.5%
286,571
+14.1%
0.00%0.0%
Q1 2019$7,299,000
+37.8%
251,142
-37.8%
0.00%0.0%
Q4 2018$5,296,000
-29.5%
403,629
+8.6%
0.00%0.0%
Q3 2018$7,516,000
-13.3%
371,746
+1.4%
0.00%
-25.0%
Q2 2018$8,671,000
+19.3%
366,630
+13.7%
0.00%
+33.3%
Q1 2018$7,266,000
-18.5%
322,588
+12.9%
0.00%
-25.0%
Q4 2017$8,910,000
-4.4%
285,746
-4.3%
0.00%0.0%
Q3 2017$9,316,000
+642.3%
298,513
+308.3%
0.00%
+300.0%
Q2 2017$1,255,000
-19.5%
73,119
-17.9%
0.00%0.0%
Q1 2017$1,559,000
+18.6%
89,072
-10.4%
0.00%0.0%
Q4 2016$1,314,000
-7.3%
99,386
+1.9%
0.00%0.0%
Q3 2016$1,418,000
-52.7%
97,568
-67.9%
0.00%
-50.0%
Q2 2016$2,998,000
+3.1%
303,803
+32.3%
0.00%0.0%
Q1 2016$2,908,000
-17.2%
229,579
+18.6%
0.00%0.0%
Q4 2015$3,513,000
-8.0%
193,637
-5.9%
0.00%0.0%
Q3 2015$3,819,000
-19.2%
205,709
+6.3%
0.00%
-33.3%
Q2 2015$4,728,000
+67.0%
193,598
+42.3%
0.00%
+50.0%
Q1 2015$2,831,000
+52.6%
136,088
+13.5%
0.00%
+100.0%
Q4 2014$1,855,000
-81.1%
119,917
-84.1%
0.00%
-83.3%
Q3 2014$9,830,000
-30.3%
753,315
+6.7%
0.01%
-25.0%
Q2 2014$14,106,000
-20.7%
706,003
-24.4%
0.01%
-27.3%
Q1 2014$17,781,000
+34.0%
934,020
+19.8%
0.01%
+37.5%
Q4 2013$13,267,000
+2.5%
779,879
-6.0%
0.01%0.0%
Q3 2013$12,945,000
+1398.3%
829,250
+1048.6%
0.01%
+700.0%
Q2 2013$864,00072,1940.00%
Other shareholders
INSMED INC shareholders Q2 2018
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 1,056,797$33,965,00014.39%
Palo Alto Investors LP 6,032,956$193,899,00010.64%
Sycale Advisors (NY) LLC 360,829$11,597,0009.99%
Burrage Capital Management LLC 165,400$5,316,0004.20%
First Light Asset Management, LLC 1,025,341$32,954,0003.38%
Rubric Capital Management LP 1,100,000$35,354,0003.30%
Sofinnova Investments, Inc. 615,143$19,771,0001.47%
Endurant Capital Management LP 144,313$4,638,0001.37%
Parkwood LLC 70,235$5,514,0000.85%
Novo Holdings A/S 430,107$13,824,0000.69%
View complete list of INSMED INC shareholders